MedTrace Logo

Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

NCT01610804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2012-06-04

No results posted yet for this study

Summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Conditions

  • Choroidal Thickness

Sponsors & Collaborators

  • University Hospital Regensburg

    lead OTHER

Principal Investigators

  • Maria A Gamulescu, PD Dr. med. · University Hospital Regensburg

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-11-30
Completion
2012-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01610804 on ClinicalTrials.gov